[
    [
        {
            "time": "2020-02-14",
            "original_text": "特免血浆治新冠肺炎推动概念股大涨 行业内认为不会带来直接业绩增长",
            "features": {
                "keywords": [
                    "特免血浆",
                    "新冠",
                    "概念股",
                    "业绩增长"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物制品"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "特免血浆治新冠肺炎推动概念股大涨 行业内认为不会带来直接业绩增长",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 6,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-02-14",
            "original_text": "“抗疫”血浆概念板块大涨 血液制品市场潜力将达400亿元",
            "features": {
                "keywords": [
                    "抗疫",
                    "血浆",
                    "概念板块",
                    "市场潜力"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物制品"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "“抗疫”血浆概念板块大涨 血液制品市场潜力将达400亿元",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-02-14",
            "original_text": "“血清疗法”功效多大？国家队组团参与新冠病毒临床治疗，天坛生物强势领涨血制品概念股",
            "features": {
                "keywords": [
                    "血清疗法",
                    "国家队",
                    "新冠病毒",
                    "天坛生物",
                    "血制品"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物制品"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "“血清疗法”功效多大？国家队组团参与新冠病毒临床治疗，天坛生物强势领涨血制品概念股",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-02-14",
            "original_text": "新冠特免血浆投入临床，血制品板块投资机会来了吗？",
            "features": {
                "keywords": [
                    "新冠",
                    "特免血浆",
                    "临床",
                    "血制品",
                    "投资机会"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物制品"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "新冠特免血浆投入临床，血制品板块投资机会来了吗？",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-02-14",
            "original_text": "抗疫“神兵天降”！这只股票发出“起飞令”，概念板块下周直上云霄？",
            "features": {
                "keywords": [
                    "抗疫",
                    "股票",
                    "起飞令",
                    "概念板块"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物制品"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "抗疫“神兵天降”！这只股票发出“起飞令”，概念板块下周直上云霄？",
                "Correlation": 8,
                "Sentiment": 9,
                "Importance": 6,
                "Impact": 8,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 10,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-02-14",
            "original_text": "血浆抗体能有效杀死新冠病毒？ 多家公司纷纷回应丨公司问答",
            "features": {
                "keywords": [
                    "血浆抗体",
                    "新冠病毒",
                    "公司回应"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物制品"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "血浆抗体能有效杀死新冠病毒？ 多家公司纷纷回应丨公司问答",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-02-14",
            "original_text": "天坛生物：正在了解核实相关情况丨公司问答",
            "features": {
                "keywords": [
                    "天坛生物",
                    "核实",
                    "相关情况"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物制品"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "天坛生物：正在了解核实相关情况丨公司问答",
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 9,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-02-14",
            "original_text": "1个人血浆可治疗11名患者 新冠肺炎输“血”疗法获关注",
            "features": {
                "keywords": [
                    "血浆",
                    "治疗",
                    "新冠肺炎",
                    "疗法"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物制品"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "1个人血浆可治疗11名患者 新冠肺炎输“血”疗法获关注",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-02-14",
            "original_text": "血浆中含有救命的“神奇抗体”！这些上市公司开始发力！",
            "features": {
                "keywords": [
                    "血浆",
                    "神奇抗体",
                    "上市公司"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物制品"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "血浆中含有救命的“神奇抗体”！这些上市公司开始发力！",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 7,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        }
    ]
]